Atlas FDA

INTERSTIM THERAPY FOR BOWEL CONTROL

FDA premarket approval P080025/S047 · decided 2013-06-17

Approval details

PMA number
P080025
Supplement
S047
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INTERSTIM THERAPY FOR BOWEL CONTROL
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2013-02-08
Decision date
2013-06-17
Days to decision
129 days
Decision code
APPR
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL FOR A CHANGE TO A SOFTWARE-BASED SYSTEM FOR INCOMING INSPECTION.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23